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Chronic pancreatitis (CP), a progressive and debili­
tating disease that usually presents with pain, is 
frequently attributed to alcohol misuse. Patients 
generally present for treatment in their fourth decade 
after recurring absenteeism and job loss; some 
have become (or have always been) indigent. There is a need for 
prevention. A potentially important consideration is the relationship 
between CP, depression and substance use disorders (SUDs), which 
seems to be circular and multiplicative.
Pain, depression and substance abuse
Compared with people in good health, ‘depression is approximately 
two to three times more common in people with a chronic physical 
health problem’.[1] In their article discussing the neurobiology and 
clinical presentation of pain and its synergies with SUD, Savage et al.[2] 
stated: ‘Pain and substance abuse co­occur frequently, and each can 
make the other more difficult to treat’; ‘each may reinforce components 
of the other’; and ‘depression is the most common psychiatric symptom 
seen among pain patients’. They found that clinicians’ fear that patients 
might develop SUD with opioid treatment for pain compromised 
effective treatment.[2] Mavandadi et al.[3] found that pain ‘may hinder 
or minimize treatment­related improvements in depressive symptoms’. 
Concerns about substance dependence resulting from opioid use 
may therefore contribute to inadequate pain relief and also lead to 
suboptimal response to treatment of depression, while potentially 
contributing towards depressive symptoms. The interplay of these 
factors has clear implications for the management of CP and calls for a 
multidisciplinary approach to optimise outcome.
Diagnosis of depression
Depression is frequently undetected and untreated. While poor 
socioeconomic status can predispose people to depression, which can 
begin in childhood or adolescence, it can also make diagnosis and 
treatment less likely. Other risk factors for a depressive disorder include 
alcohol abuse, stressful life events, adverse childhood experiences, job 
loss, close personal relationship problems, poverty, and a family history 
of depression. Severe pain is a major contributor to depression, and pain 
amelioration can improve collaborative care interventions for depression.
In 1985 David Goldberg[4] identified five main reasons why patients 
failed to have their psychiatric conditions diagnosed by physicians: they 
would not be asked directly about their psychological conditions; only 
somatic symptoms would be discussed; privacy during consultations 
would be lacking; there would be an exclusive focus on organic causes 
of symptoms; and physicians lacked confidence in their ability to make 
psychiatric assessments. Ideally, consultants should have knowledge 
of the culture of origin of patients with depression, within a holistic 
biopsychosocial approach to disease management. Knowledge of 
the social environment of such patients is critical for determining 
what measures can be taken to improve their circumstances and thus 
contribute to amelioration of depression. Social workers from the 
community are well placed to facilitate such measures.
Depression and physical illness
Objective evidence on the incidence and severity of depression in com­
bination with chronic physical health problems is not available.[1] Somatic 
symptoms of the latter can occur with, and mask, the symptoms of 
the former, making distinction between the two problematic.[1] The 
simultaneous presence of both increases the likelihood and extent of 
functional, social and occupational disabilities, and may lead to shorter 
life expectancies. Depression worsens medical prognosis and may play 
an aetiological role in SUD and CP. In 2000, DiMatteo et al.[5] found that 
depressed patients with physical illness were ‘three times more likely to 
be non­compliant with treatment recommendations’. Although active 
treatment for depression may have a lesser beneficial effect for severe pain, 
and may not improve length of survival, it improves quality of survival.
Chronic pancreatitis, substance abuse 
and depression
Depression and low self­esteem arising from poor education and 
unemployment are associated with high­risk behaviours such as 
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substance abuse, while SUD can be both the cause and effect of 
depression. Wehler et al.[6] lamented the lack of knowledge about 
poor mental health in patients with CP and noted that a substantially 
increased risk for onset of major depressive disorders arises from 
alcohol abuse. Such a causal link has also been suggested by 
Fergusson et al.[7] Drug addiction has been cited as a complication 
of depressive disorders, and dependence on opioids can result from 
their use as prescribed treatment for CP pain. Unemployment may be 
a predictor of abuse of prescription opioids and vice versa, while both 
increase dependence on disability grants.
Chronic pancreatitis, surgery and  
pain management
The Frey procedure (local resection of the pancreatic head with 
late ral pancreaticojejunostomy) undertaken at the Hepatopancreato­
biliary (HPB) Unit in the Department of Surgery at Chris Hani 
Baragwanath Academic Hospital, Johannesburg, South Africa, 
between 2002 and 2009 improved quality of life and functioning 
and reduced symptoms in 32 patients with painful CP.[8] The median 
duration of pain before surgery was 72 months (range 10 ­ 264). 
There was no significant correlation between preoperative pain 
duration and the pain score or pain intensity of the 32 patients. The 
traditional view that with time there is ‘burn­out’ of pain has been 
invalidated,[8­10] and deferment of surgery in anticipation of future 
‘burn­out’ is therefore not appropriate. Rather, deferment of surgery 
increases the risk of dependence on opioids.
In a later unpublished study from the same authors, 35 patients 
treated between 2009 and 2012 answered a structured interview 
before and after the Frey procedure in the HPB Unit. All patients 
answered questions relating to hopelessness and pain, as measured 
on a visual analogue scale from 0 to 10. The use of prescribed opioids 
was recorded at both interviews. The duration of postoperative 
follow­up was a mean of 27.5 months (standard deviation 24.9). 
Before surgery, 68.6% of the patients felt hopeless, 100% had a pain 
score of ≥5, and 38.2% were using prescribed opioids. After surgery, 
at the last recorded visit, 34.3% felt hopeless, 54.5% had pain ≥5, and 
there was an increase in the use of prescribed opioids to 64.7% of 
the sample. The increasingly liberal prescribing of opioids has raised 
concern about dependence and deleterious side­effects.[11] Misuse 
of opioids for the relief of depression can lead to behaviours that 
exaggerate pain in order to increase the amount of opioids prescribed. 
In a rare study on interventions for alcohol abuse in patients with 
alcohol use disorders and painful pancreatitis, a reduction in alcohol 
consumption and a decreased need for analgesics was achieved by a 
multidisciplinary group of pancreatic surgeons and addiction and 
pain specialists.[12]
Conclusion
The use of adequate analgesia is a key component in preventing 
depressive symptoms, but may promote substance dependence 
and abuse. The clinician is therefore caught in a double bind. 
Pain management in the context of chronic illness requires a bio­
psychosocial approach aiming for a tailored intervention that strikes 
an appropriate therapeutic balance.
Surgeons, pain and addiction clinicians working in collaboration 
with nurses, social workers, psychologists and psychiatrists can 
contribute to improved quality of life for patients with CP, and raise 
professional and public awareness at all levels of healthcare.
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